231 related articles for article (PubMed ID: 14577328)
1. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
Endo T
Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation in congenital muscular dystrophies.
Endo T; Toda T
Biol Pharm Bull; 2003 Dec; 26(12):1641-7. PubMed ID: 14646163
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
4. Glycobiology of α-dystroglycan and muscular dystrophy.
Endo T
J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
6. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
7. Fukutin and alpha-dystroglycanopathies.
Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
[TBL] [Abstract][Full Text] [Related]
8. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
Yoshida A; Kobayashi K; Manya H; Taniguchi K; Kano H; Mizuno M; Inazu T; Mitsuhashi H; Takahashi S; Takeuchi M; Herrmann R; Straub V; Talim B; Voit T; Topaloglu H; Toda T; Endo T
Dev Cell; 2001 Nov; 1(5):717-24. PubMed ID: 11709191
[TBL] [Abstract][Full Text] [Related]
9. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease.
Manya H; Sakai K; Kobayashi K; Taniguchi K; Kawakita M; Toda T; Endo T
Biochem Biophys Res Commun; 2003 Jun; 306(1):93-7. PubMed ID: 12788071
[TBL] [Abstract][Full Text] [Related]
10. O-mannosyl glycans in mammals.
Endo T
Biochim Biophys Acta; 1999 Dec; 1473(1):237-46. PubMed ID: 10580142
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents.
Zhang W; Vajsar J; Cao P; Breningstall G; Diesen C; Dobyns W; Herrmann R; Lehesjoki AE; Steinbrecher A; Talim B; Toda T; Topaloglu H; Voit T; Schachter H
Clin Biochem; 2003 Jul; 36(5):339-44. PubMed ID: 12849864
[TBL] [Abstract][Full Text] [Related]
12. The role of the GlcNAc(beta)1,2Man(alpha)- moiety in mammalian development. Null mutations of the genes encoding UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2 cause embryonic lethality and congenital muscular dystrophy in mice and men, respectively.
Schachter H
Biochim Biophys Acta; 2002 Dec; 1573(3):292-300. PubMed ID: 12417411
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
14. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
15. O-mannosylation in mammalian cells.
Endo T; Manya H
Methods Mol Biol; 2006; 347():43-56. PubMed ID: 17072003
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation defects in inherited muscle disease.
Hewitt JE; Grewal PK
Cell Mol Life Sci; 2003 Feb; 60(2):251-8. PubMed ID: 12678490
[TBL] [Abstract][Full Text] [Related]
17. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
Toda T; Kobayashi K; Takeda S; Sasaki J; Kurahashi H; Kano H; Tachikawa M; Wang F; Nagai Y; Taniguchi K; Taniguchi M; Sunada Y; Terashima T; Endo T; Matsumura K
Congenit Anom (Kyoto); 2003 Jun; 43(2):97-104. PubMed ID: 12893968
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features.
Haliloglu G; Gross C; Senbil N; Talim B; Hehr U; Uyanik G; Winkler J; Topaloglu H
Acta Myol; 2004 Dec; 23(3):137-9. PubMed ID: 15938569
[TBL] [Abstract][Full Text] [Related]
19. Structure, function and pathology of O-mannosyl glycans.
Endo T
Glycoconj J; 2004; 21(1-2):3-7. PubMed ID: 15467391
[TBL] [Abstract][Full Text] [Related]
20. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
Martin-Rendon E; Blake DJ
Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
